1997
DOI: 10.1016/s0939-6411(97)00100-8
|View full text |Cite
|
Sign up to set email alerts
|

An in vitro-in vivo investigation of oral bioadhesive controlled release furosemide formulations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

2
26
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(29 citation statements)
references
References 14 publications
2
26
0
Order By: Relevance
“…Therefore different approaches have been proposed to retain the dosage form in the stomach. These include bioadhesive systems (Santus, et al 1997), swelling and expanding systems (Deshpande et al 1996) and floating systems (Menon et al 1994). In some cases, gastro retention is achieved by concomitant administration of drugs or excipientswhich slow the motility of GIT (Moes 1994).…”
Section: Introductionmentioning
confidence: 99%
“…Therefore different approaches have been proposed to retain the dosage form in the stomach. These include bioadhesive systems (Santus, et al 1997), swelling and expanding systems (Deshpande et al 1996) and floating systems (Menon et al 1994). In some cases, gastro retention is achieved by concomitant administration of drugs or excipientswhich slow the motility of GIT (Moes 1994).…”
Section: Introductionmentioning
confidence: 99%
“…Several approaches are currently used to retain the dosage form in the stomach. These include bioadhesive systems [5], swelling and expanding systems [6,7], floating systems [8,9], and other delayed gastric emptying devices [10,11]. The principle of floating preparation offers a simple and practical approach to achieve increased gastric residence time for the dosage form and sustained drug release.…”
Section: Introductionmentioning
confidence: 99%
“…The suggested adult oral dosage of ranitidine is 150 mg twice daily or 300 mg once daily. The effective treatment of erosive esophagitis requires administration of 150 mg of ranitidine 4 times a day [2]. For the short term symptomatic relief of heartburn or non-ulcer dyspepsia a dose of 120 mg up to twice daily is suggested [3].…”
Section: Introductionmentioning
confidence: 99%